Table 3.
Practical concise recommendations for the clinicians
Type of ICM intervention | At-risk group | Action |
---|---|---|
Intravenous ICM | eGFR < 30 ml/min | Re-analyse the necessity of ICM administration Check for metformin – withdraw Hydrate the patient if clinically indicated Interval of 48 hours between consecutive ICM administrations For in-patients, check eGFR 48-72 hours following ICM administration For outpatients, check eGFR in case of worsening of the clinical status following ICM administration |
Intraarterial ICM with a first-pass exposure | eGFR < 40 ml/min | As above |
Intraarterial ICM with a second-pass exposure | eGFR < 30 ml/min | As above |
The gadolinium-based procedure with the lowest-risk media | None | None |